Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1990. Upgrade now.
Date Value
September 30, 2024 -4.636B
June 30, 2024 -2.459B
March 31, 2024 -4.931B
December 31, 2023 5.442B
September 30, 2023 -3.779B
June 30, 2023 27.17B
March 31, 2023 -2.771B
December 31, 2022 -5.015B
September 30, 2022 -5.761B
June 30, 2022 2.52B
March 31, 2022 -6.578B
December 31, 2021 -3.351B
September 30, 2021 -1.101B
June 30, 2021 -2.557B
March 31, 2021 -2.807B
December 31, 2020 -13.79B
September 30, 2020 -2.821B
June 30, 2020 9.159B
March 31, 2020 -2.20B
December 31, 2019 -2.44B
September 30, 2019 3.273B
June 30, 2019 -851.00M
March 31, 2019 -8.467B
December 31, 2018 -6.407B
September 30, 2018 -1.406B
Date Value
June 30, 2018 -1.908B
March 31, 2018 -10.72B
December 31, 2017 -3.743B
September 30, 2017 -1.711B
June 30, 2017 -2.989B
March 31, 2017 -4.907B
December 31, 2016 -2.313B
September 30, 2016 -1.662B
June 30, 2016 1.918B
March 31, 2016 -7.171B
December 31, 2015 -1.294B
September 30, 2015 -263.00M
June 30, 2015 -1.874B
March 31, 2015 -6.978B
December 31, 2014 -3.127B
September 30, 2014 -2.887B
June 30, 2014 -2.04B
March 31, 2014 -2.133B
December 31, 2013 -5.744B
September 30, 2013 -5.631B
June 30, 2013 -4.034B
March 31, 2013 434.00M
December 31, 2012 -6.233B
September 30, 2012 -3.291B
June 30, 2012 -2.968B

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-13.79B
Minimum
Dec 2020
27.17B
Maximum
Jun 2023
-1.135B
Average
-2.789B
Median

Cash from Financing (Quarterly) Benchmarks

Amgen Inc -3.651B
Johnson & Johnson -9.882B
Eli Lilly and Co 211.30M
Merck & Co Inc -2.425B
Moderna Inc 11.00M